Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer

Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer

Purpose: While brachytherapy is often used concurrently with flap reconstruction following surgical ablation for head and neck cancer, it remains unclear whether it increases morbidity in the particularly high risk subset of patients undergoing salvage treatment for recurrent head and neck cancer (...

Full description

Bibliographic Details
Main Authors: Peter W. Henderson, David I. Kutler, Bhupesh Parashar, David M. Otterburn, Marc A. Cohen, Jason A. Spector
Format: Article
Language:English
Published: Termedia Publishing House 2016-08-01
Series:Journal of Contemporary Brachytherapy
Subjects:
brachytherapy
flap reconstruction
head and neck cancer
HDR
LDR
Online Access:https://www.termedia.pl/Neither-high-dose-nor-low-dose-brachytherapy-increases-flap-morbidity-in-salvage-treatment-of-recurrent-head-and-neck-cancer,54,28243,1,1.html

Internet

https://www.termedia.pl/Neither-high-dose-nor-low-dose-brachytherapy-increases-flap-morbidity-in-salvage-treatment-of-recurrent-head-and-neck-cancer,54,28243,1,1.html

Similar Items